Read More Pharma Industry News Furoscix ReadyFlow approval triggers $45m bill as MannKind Corporation raises fresh capital MannKind Corporation wins Furoscix ReadyFlow approval and raises $50 million as a $45 million acquisition payment reshapes the outlook. bySoujanya RaviJuly 27, 2026